Primary Hyperparathyroidism Clinical Trial
Official title:
Feasibility of Parathyroidectomy With Exploration of 4 Parathyroid Glands in Outpatients, for Treatment of Primary Hyperparathyroidism
The development of outpatient surgery has become a national priority, with the objective of
an ambulatory surgery rate of around 50% in 2016, whereas this rate reached only 37.7% in
2010.
In the context of the management of primary hyperparathyroidism, there are two possible
approaches. The first, which is commonly performed on an outpatient basis, consists in
approaching only the pathological gland, if it was first identified by scintigraphy and
ultrasound (which is the case in one patient in two), without exploring the others
parathyroid glands.
The reference technique consists in exploring the 4 parathyroid sites by transverse
cervicotomy. Although more invasive, it minimizes the risk of failure due to the lack of
knowledge of multi-glandular forms of the disease (15 to 20%), whose preoperative diagnosis
is difficult. This reference technique is poorly performed on an outpatient basis while it
lends itself to this type of management because of the superficial character of the operative
site, a short operating time, moderate postoperative pain, rapid return oral nutrition and
exceptional and early serious complications (delay <24 h for cervical hematoma, <24 h for
hypocalcemia and immediate diagnosis of recurrent palsy).
In this study, the investigators hypothesize that parathyroidectomy with 4-gland parathyroid
exploration is feasible by ensuring patient safety. The investigators also believe that
outpatient management will not lead to any difference after 3-month surgery, but will reduce
hospitalization costs while increasing patient satisfaction with conventional care. To do so,
the investigators carried out an observational cohort study of patients with an indication of
parathyroidectomy wo will undergo outpatient management or conventional management (stay
overnight in hospital) to inform all of these data.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT03931109 -
Circulating miRNA in Primary Hyperparathyroidism
|
||
Completed |
NCT04305561 -
Preoperative Localization Strategies in Primary Hyperparathyroidism
|
N/A | |
Recruiting |
NCT03052075 -
Percent Change in Baseline Bone Mineral Density (BMD) After Parathyroidectomy in Patients With Primary Hyperparathyroidism
|
||
Completed |
NCT03774771 -
Safety, Pharmacokinetics, and Clinical Effects of Cinacalcet (AMG 073) in Primary Hyperparathyroidism
|
Phase 2 | |
Recruiting |
NCT02854345 -
Preliminary Study Concerning the Validity of Parathyroid Exploration on a CZT Camera
|
N/A | |
Completed |
NCT01222026 -
Systematic Treatment After Successful Surgical Treatment for Primary Hyperparathyroidism With Strontium Ranelate
|
Phase 4 | |
Recruiting |
NCT00973336 -
Primary Hyperparathyroidism: Does a Systematic Treatment Improve the Calcium and Bone Metabolism After Surgery?
|
Phase 2 | |
Completed |
NCT01530919 -
Minimally Invasive Radioguided Parathyroidectomy
|
N/A | |
Recruiting |
NCT03605472 -
Comparison of Cervical Ultrasound and Echoscintigraphy for Preoperative Localization Diagnosis in Primary Hyperparathyroidism
|
N/A | |
Completed |
NCT01306656 -
Vitamin D Repletion in Primary Hyperparathyroidism
|
Phase 4 | |
Terminated |
NCT00961701 -
Lipids Profile in Primary Hyperparathyroidism
|
N/A | |
Completed |
NCT00432939 -
Primary Hyperparathyroidism: Non-classical Manifestations
|
N/A | |
Completed |
NCT00522028 -
Asymptomatic Primary Hyperparathyroidism: A Prospective, Randomized Trial
|
N/A | |
Completed |
NCT03713671 -
Gait and Balance Parameters Before and After Parathyroidectomy in Patients With Primary Hyperparathyroidism
|
N/A | |
Recruiting |
NCT04969926 -
Natural History Study of Parathyroid Disorders
|
||
Recruiting |
NCT03039439 -
Molecular and Immunohistochemical Profiling of Tumors in Patients With Parathyroid Tumors
|
||
Completed |
NCT01996072 -
EC17 for Intraoperative Imaging for Parathyroidectomy
|
Phase 1 | |
Completed |
NCT01460030 -
An Intra-individual Titration Study of KRN1493 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Intractable Primary Hyperparathyroidism
|
Phase 3 | |
Enrolling by invitation |
NCT04085419 -
Osteoporosis in Primary Hyperparathyroidism
|
Phase 4 | |
Recruiting |
NCT03935984 -
Calcitonin Pre-treatment to Improve SPECT-CT Sensitivity
|
Phase 4 |